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Abstract Objective: To investigate whether physicians’
attitudes towards treatment guidelines for primary and
secondary care differ between teaching and nonteaching
hospitals shortly before and 4 years after the guidelines’
introduction. Methods: Possible barriers and facilitators
of joint treatment guidelines were obtained by self-
administered questionnaires twice during the study period.
Questionnaires were distributed among all internists and
cardiologists in the Groningen region of The Netherlands.
Results: Physicians from teaching and nonteaching hos-
pitals differed in attitude regarding the content and
usefulness of the guidelines. Physicians from nonteaching
hospitals more often believed that the guidelines are too
restrictive (64% vs. 18%) and too rigid to apply to
individual patients (14% vs. 6%) and that they over-
simplify medical practice (79% vs. 35%). Physicians from
teaching hospitals more often agreed that good recom-
mendations for first-choice drugs had been made (76% vs.
50%) and that these guidelines are a convenient source of
advice (94% vs. 57%), can facilitate communication with
general practitioners (94% vs. 71%), and can improve the
quality of pharmacotherapeutic care (88% vs. 43%). Four
years later, a larger proportion of physicians from both
hospital settings had a negative attitude towards the
usefulness of the guidelines, but the difference in attitude
between teaching and nonteaching hospitals remained the
same. Conclusion: Physicians from nonteaching hospi-
tals were less positive about the usefulness of joint
treatment guidelines than physicians from teaching hos-
pitals were. Results from studies on the implementation of
guidelines in teaching hospitals can therefore not be
transferred to nonteaching settings.
Introduction
Treatment guidelines have evolved greatly in the past 20
years and are regarded as the cornerstone in improved
health quality and medical cost control. However, their
implementation has proved to be difficult [1, 2]. Under-
standing physicians’ attitudes towards guidelines may be
helpful in creating strategies to successfully implement
them.
In the year 2000, several programmes were set up in The
Netherlands to improve the quality and consistency of
therapeutic care between primary and secondary care. The
approach chosen in several regions was to develop joint
treatment guidelines to be used both by hospital physicians
and general practitioners (GPs). In Groningen, a region in
the north of The Netherlands, new guidelines were devel-
oped by local committees of hospital physicians, GPs, and
community and hospital pharmacists. They used available
evidence as well as existing national guidelines and local
formularies for either primary or secondary care to es-
tablish these joint treatment guidelines. Drugs of first
choice were chosen for all relevant indications and
subpopulations.
Previous research showed that hospital physicians ex-
pressed both positive and negative attitudes towards the
regional joint treatment guidelines [3]. Other studies found
that most hospital physicians had a positive attitude
towards guidelines in general, perceiving them to be of
educational value and likely to improve quality of care [4–7].
However, physicians also expressed concerns that guidelines
were too rigid to apply to individual patients and that they
reduced physician autonomy [4, 5, 7]. Physicians’ attitudes
may differ between settings because of differences in
organisational culture and patient populations [8–11]. Little
is known about differences in physicians’ attitudes across
hospital settings. We investigated whether physicians’
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attitudes towards regional joint treatment guidelines differed
between teaching and nonteaching hospitals shortly before
the guidelines’ introduction and 4 years later.
Methods
Setting
As part of a larger study evaluating the usefulness of
cardiovascular treatment guidelines, we surveyed all
general internists and cardiologists in the Groningen
region. This region includes five hospitals, 260 GPs, and
570,000 inhabitants. One hospital is a large university
hospital where physicians are employed by the hospital.
The second is a large teaching hospital where physicians
work in private group practices. The remaining three
hospitals are nonteaching hospitals where physicians also
work in private group practices.
Guideline development and implementation
The first version of the joint treatment guidelines covered
16 therapeutic indications for different specialties. For
most of the included topics, local or national guidelines
already existed but were intended primarily for either GPs
or specialists. The newly developed guidelines were unique
by combining recommendations for both professional
groups, thereby streamlining treatment choices across the
primary-secondary care interface. The first version of the
guidelines was distributed to all health care providers by
mail in 2001. In 2004, the guidelines were updated and
expanded to cover 43 topics. They were again distributed
by mail.
During the first 4 years, the local institute for rational
drug use developed a few implementation projects for GPs,
but no specific programme was developed to implement
the joint treatment guidelines in the hospitals. Hospital
physicians received only a general newsletter about the
regional project twice a year.
Data collection
Possible differences in barriers and facilitators of joint
treatment guidelines between teaching and nonteaching
hospitals were obtained by self-administered question-
naires twice during the study period. The first questionnaire
was given to all 36 general internists and 24 cardiologists
working in the Groningen region at the end of 2000, shortly
before the introduction of the joint treatment guidelines. In
the second survey, the group of internists was expanded
with the subspecialties endocrinology and nephrology to a
total number of 54, and the number of cardiologists
working in the region had increased to 36. The second
questionnaire was mailed to all these internists and
cardiologists in the autumn of 2004, after the updated
version of the guidelines had become available. A single
reminder letter and a second copy of the questionnaire were
sent to nonrespondents 3 weeks later.
Questionnaires were developed using statements from
existing instruments, such as the Attitudes Towards
Guidelines Scale [12], and were supplemented by state-
ments derived from previous qualitative research among
hospital physicians [13]. The first questionnaire included
34 statements of possible barriers and facilitators of joint
treatment guidelines that covered four domains: content of
the guidelines (eight items), development process of the
guidelines (four items), usefulness and value (15 items),
and aspects of organisation and setting (seven items) [3].
The follow-up questionnaire included statements about
physicians’ perceived usefulness and value of the guide-
lines on which physicians differed at the time of the
introduction (eight items). Attitudes about guidelines were
assessed using 7-point ordinal scales, with 1 indicating
“strongly agree” and 7 indicating “strongly disagree”. The
7-point ordinal scales were collapsed into categories of
agreement (response 1–3), neutral (response 4), and
disagreement (responses 5–7).
Data analysis
Differences in demographic characteristics between physi-
cians from teaching and nonteaching hospitals and between
participants and the regional physician population were
tested with chi-square tests. Chi-square tests were also used
to determine differences in survey responses between
physicians from the two teaching hospitals and three
nonteaching hospitals and to assess possible differences in
attitudes between early and late respondents and between
respondents on the first and second surveys.
Results
First survey
Thirty-one physicians, 15 general internists and 16
cardiologists, completed the questionnaires during the
first survey (response rate 52%). The mean and standard
deviation of age was 47±7 years; two physicians (6%) were
women; and 17 (55%) were working in teaching hospitals.
This was not significantly different from the entire group of
cardiologists and internists in the Groningen region at that
time in terms of gender or percentage of physicians
working in teaching hospitals. There were also no signif-
icant differences between physicians from teaching and
nonteaching hospitals with respect to age, gender, or
specialty.
Physicians from teaching and nonteaching hospitals
differed in attitude regarding two of the eight items dealing
with the guidelines’ content and six of the 15 items
focussing on the usefulness and value of the guidelines.
More physicians from nonteaching hospitals compared
with those from teaching hospitals considered the guide-
lines to be too restrictive and did not agree with the
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recommendations made for first-choice drugs (Table 1).
Physicians from nonteaching hospitals more often believed
that the guidelines were too rigid to apply to individual
patients and that they oversimplified medical practice. In
addition, physicians from nonteaching hospitals agreed less
often that these guidelines could facilitate communication
with GPs or could improve the quality of pharmacother-
apeutic care.
Almost half of the physicians from teaching hospitals
and more than two-thirds of the physicians from nonteach-
ing hospitals perceived no need to use the guidelines.
Physicians from nonteaching hospitals also seemed to have
more reservations regarding the organisational aspects of
implementing these guidelines, but none of these differ-
ences were statistically significant.











Agree Disagree Agree Disagree
Guideline content
These guidelines are based on scientific evidence 94 6 86 0
These guidelines recommend what I already do in practice 88 6 93 0
Within drug classes, good choices have been made in these guidelines 76 24 50 14 p=0.03
These guidelines are outdated 24 59 43 36
These guidelines are too restrictive 18 71 64 21 p=0.02
These guidelines are too conservative 18 71 36 43
Too many equivalent drugs are included in these guidelines 6 82 7 71
These guidelines should have given recommendations on drug class level only 35 59 75 25
Guideline development process
The people in the developing committees are appropriate representatives of my
professional group
63 19 71 14
These guidelines are developed by experts 94 0 93 7
The guideline development initiative is dominated too much by financial interests 50 19 79 0
The distance between the developers of these guidelines and practitioners is too big 44 19 50 14
Usefulness and value of guidelines
These guidelines are useful as an educational tool 94 0 79 21
These guidelines are a convenient source of advice 94 0 57 29 p=0.03
These guidelines can facilitate communication with general practitioners 94 0 71 29 p=0.05
These guidelines can facilitate communication with patients and families 59 24 43 43
These guidelines can improve the quality of pharmacotherapeutic care 88 0 43 21 p=0.02
These guidelines can lead to better harmony between primary and secondary care 88 6 92 8
These guidelines can lead to cost savings 59 12 57 29
These guidelines are well-applicable in practice 88 0 57 14
These guidelines facilitate taking over patients from colleagues 59 24 50 36
These guidelines can be misused by government and insurance companies 59 18 93 7
These guidelines limit innovation 47 47 79 21
I do not need these guidelines 47 41 71 21
These guidelines challenge my professional autonomy 19 69 79 14 p<0.01
These guideline oversimplify medical practice 35 47 79 14 p=0.05
Many of my patients cannot be treated according to these guidelines 6 88 14 43 p=0.03
Organisation and setting
Most of my colleagues have disapproving attitudes about these guidelines 18 65 29 36
These guidelines are not valued in my practice organisation 12 59 21 21
Implementing these guidelines is too time-consuming and expensive 12 65 50 36
With these guidelines I lose industry support for conducting research 35 65 36 57
With these guidelines I lose industry support for conferences and educational meetings 24 65 50 43
Some of my patients do not want to be treated according to these guidelines 18 65 54 38
These guidelines thwart local guidelines and agreements 0 76 21 64
aComparing numbers of specialists and general practitioners agreeing, disagreeing, or having a neutral opinion; only p-values ≤0.05 are
reported
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Most physicians agreed that the guidelines were devel-
oped by experts (93%), useful as an educational tool
(87%), well-applicable in practice (74%), and likely to
improve harmonisation between primary and secondary
care (90%). Physicians from teaching hospitals in partic-
ular agreed that the guidelines were a convenient source of
advice. At the same time, many physicians expressed
concerns about misuse of these guidelines by government
and insurance companies (74%) and negative influence of
guidelines on innovation (61%). Many physicians reported
that the guideline development initiative was dominated
too much by financial interests (63%).
Second survey
Of the 90 physicians surveyed 4 years after the introduction
of the regional joint treatment guidelines, 50 (56%)
responded to the survey, 32 internists and 18 cardiologists.
Participating physicians had a mean age of 47±8 years; six
(12%) were women; and 38 (76%) were working in
teaching hospitals. This was representative for the entire
group of cardiologists and internists in the Groningen re-
gion at that time in terms of gender and percentage of
physicians working in teaching hospitals.
Overall, a larger proportion of physicians from both
hospital settings had a negative attitude towards usefulness
and value of the guidelines at the second survey, but the
differences in attitudes between teaching and nonteaching
hospitals remained similar (Table 2). Comparing the first
and the second surveys as independent samples, signifi-
cantly more negative attitudes were observed for three of
the eight statements (chi-square tests, p<0.05).
Late respondent analysis
On average, 40% of the late respondents (n=11) and 26%
of the early respondents (n=39) expressed neutral re-
sponses. Early respondents had more positive as well as
more negative attitudes than late respondents. Overall,
there was no significant difference in attitudes between the
early and the late respondents (chi-square test, p>0.05). In
addition, respondents and nonrespondents did not differ in
terms of gender, specialty, or percentage working in teach-
ing hospitals.
Discussion
We found that physicians from nonteaching hospitals
viewed the regional joint treatment guidelines less fa-
vourably than did physicians from teaching hospitals. Four
years after the guidelines’ introduction, more physicians
from both settings expressed a negative attitude towards
the usefulness of these guidelines, while the difference
between teaching and nonteaching hospitals remained the
same.
We evaluated the attitudes towards these guidelines
without being involved in their development or implemen-
tation. This independent status may have been an important
factor for retrieving candid answers from the respondents.
Treatment guidelines were perceived as a burden and a
source of irritation bymany hospital physicians, particularly
in nonteaching hospitals. Despite the fact that the physicians
felt adequately represented in the committees that devel-
oped the guidelines and believed that the guidelines were
based on scientific evidence, they were not content with the
idea of being faced with the guidelines themselves. Im-
portant beliefs underlying this discontent are that (1)
specialists believe they already make good drug choices
and do not need guidelines telling them what to do in their
fields of expertise, and (2) guidelines restrict the choice of
drugs to save costs for the government and insurance
companies but may lead to loss of industry support for
research and conferences. Dependence on industry sponsor-
ship for education and research can make physicians
unwilling to divert from certain brand preferences [14].
Physicians from teaching hospitals were more positive
than those from nonteaching hospitals. Explanations may








Agree Disagree Agree Disagree
Usefulness and value of guidelines
These guidelines are a convenient source of advice 66 11 50 25
These guidelines can facilitate communication with general practitioners 76 5 33 25 p=0.02
These guidelines can improve quality of pharmacotherapeutic care 61 8 27 45 p=0.01
These guidelines are well-applicable in practice 37 16 17 33
These guidelines limit innovation 45 39 67 0 p=0.03
These guidelines challenge my professional autonomy 37 39 83 0 p=0.01
Many of my patients cannot be treated according to these guidelines 26 29 58 0 p=0.04
These guidelines oversimplify medical practice 47 29 83 8
aComparing numbers of specialists and general practitioners agreeing, disagreeing, or having a neutral opinion;
only p-values ≤0.05 are reported
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lie in differences in utility of the guidelines, patient
populations, economic and organisational consequences,
and cultural differences [8–11]. Utility of the guidelines
appears to be a relevant factor in our study. In teaching
hospitals, physicians can use the guidelines in their
educational activities; therefore, they see more benefits of
having the guidelines. Surprisingly, physicians from
nonteaching hospitals expected more problems regarding
their patient population than physicians from teaching
hospitals did. This is in contrast with an earlier finding that
especially in teaching hospitals one could expect difficul-
ties with treating complex patients according to guideline
recommendations [13]. Strong physician leadership advo-
cating guideline use may be an important factor [15]. In
teaching hospitals, one can expect a stronger culture to
promote the use of evidence-based guidelines. Results
from an Italian survey suggest that there may also be
economic and organisational reasons for differences in
attitudes towards guidelines, but our study does not support
this finding [4]. Physicians from private and nonprivate
practices represented within our two teaching hospitals
showed similar attitudes. Teaching status appears to be a
more important factor than being employed by the hospital
or not.
Our study provided insight into the changing attitude
towards usefulness of treatment guidelines over time. The
finding that physicians became more negative has been
observed before, and it has been suggested that physicians’
attitudes may change as they perceive that guidelines are
being used more for cost containment than for quality
improvement [6]. This was clearly an issue of discussion in
our region, since the guidelines have been used in 2002 in
negotiations to make cost agreements with the industry.
Another factor that might have influenced changes in
attitude over time is the lack of a specific implementation
programme. The joint treatment guidelines in our study
were distributed by mail, and such passive dissemination
has been shown to be largely ineffective [16]. Supporting
strategies to implement treatment guidelines soon after
their introduction may be crucial. To motivate physicians to
start using the guidelines at present, an intensive
implementation strategy will be needed.
Our study has some limitations. Using a questionnaire is
an efficient way to examine attitudes and barriers, but
socially desirable answers may form a problem. We have
tried to limit this by using positive as well as negative
statements and by emphasising that the data would be
processed anonymously. Furthermore, the generalisation of
our findings is somewhat limited because we studied a
modest number of physicians in each hospital setting, and
not all physicians participated in both surveys. Although
we achieved response rates above 50%, response bias may
affect the results. We observed that early respondents
expressed more pronounced attitudes compared with
physicians who responded after the reminder and, possibly,
with the remaining nonrespondents. However, the early
respondents had both more positive and more negative
attitudes. Therefore, we do not expect our results to be
skewed due to response bias, for instance towards the more
discontented physicians. There were also no substantial
differences between respondents and nonrespondents with
respect to gender, specialty, or percentage of physicians
working in teaching hospitals.
In conclusion, physicians’ attitudes towards treatment
guidelines differ between teaching and nonteaching
hospitals. Up to now, most research focussing on the
implementation of treatment guidelines has been per-
formed in teaching hospitals. Considering the findings of
our study, results from such studies cannot be transferred to
nonteaching settings. One might expect more difficulties
when treatment guidelines are implemented in a nonteach-
ing hospital setting.
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